Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H7N9 Influenza Vaccine with Adjuvants IB160 or SE
NCT03330899Phase 1Completed
- Sponsor
- Instituto Butantan
- Start
- Sep 2018
- Primary completion
- Jan 2020
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in avian influenza A H7N9 virus infection (H7N9) (8 arms), sponsored by Instituto Butantan. Primary endpoints: Number of participants with solicited local Adverse Events at 7 days, Number of participants with solicited systemic Adverse Effects at 7 days and 1 more. Started Sep 2018; status: completed.
02
Conditions
avian influenza A H7N9 virus infection (H7N9)
Beyond the preview
Go deeper on NCT03330899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03330899.